ReachMD XM 157 Announces Medical Information Feature on Irritable Bowel Syndrome, Its Treatments, and the Role of ...( CHICAGO June 30 /- ReachMD XM 157...),Health

CHICAGO, June 30 /PRNewswire/ -- ReachMD XM 157 announces a new Medical Industry Feature of the Week highlighting functional GI disorders, current treatment options, and ways to build and maintain healthy digestive flora. This new programming will be sponsored by Procter & Gamble's ALIGN(R) brand.

ReachMD XM 157, the first and only network for medical professionals, will air the program entitled "Clinical Use of Probiotics in IBS" twice a day July 7-20. Healthcare professionals can tune in to XM Satellite Radio Channel 157 or listen online at http://www.ReachMD.com (Use promo code ALIGNPR)

The program features an interview with Emeran Mayer, MD, director of UCLA Center for Neurovisceral Sciences and Women's Health. Dr. Mayer authored the review article "Irritable Bowel Syndrome" recently published in the April 17, 2008 issue of The New England Journal of Medicine.

Dr. Mayer will be interviewed by program host Jeffrey Nathanson, MD, clinical instructor at Northwestern University's Feinberg School of Medicine. The topics include:

-- Digestive health - gastrointestinal disorders and bacteria balance

-- Irritable Bowel Syndrome (IBS) - statistics and facts, causes and

symptoms

-- General treatment alternatives

-- The potential role of probiotics - usage, clinical trials, and

accessibility to patients

The program is sponsored by Procter & Gamble in support of its new probiotic ALIGN dietary supplement, which helps build and maintain normal digestive health. As program sponsor, P&G will offer samples of ALIGN to health care professional listeners at the end of each show. Listeners will be able to call 888-55-ALIGN starting July 7 to request free samples and other product information.

Gary Epstein, CEO of ReachMD said, "We're proud to work with P&G to broadcast this very special program. Not only will this interview make for compell
'/>"/>